Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer

@article{Hunter2019Mir526bAM,
  title={Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer},
  author={Stephanie Hunter and Braydon Nault and Kingsley Chukwunonso Ugwuagbo and Sujit Maiti and Mousumi Majumder},
  journal={Cancers},
  year={2019},
  volume={11}
}
MicroRNAs (miRNAs) are small endogenously produced RNAs, which regulate growth and development, and oncogenic miRNA regulate tumor growth and metastasis. Tumour-associated angiogenesis and lymphangiogenesis are processes involving the release of growth factors from tumour cells into the microenvioronemnt to communicate with endothelial cells to induce vascular propagation. Here, we examined the roles of cyclo-oxygenase (COX)-2 induced miR526b and miR655 in tumour-associated angiogenesis and… Expand
MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C.
TLDR
Analysis of a miRNA microarray of colon cancer indicates that miR-182-5p regulates colon cancer tumorigenesis partially through modulating angiogenesis and lymphangiogenesis by targeting VEGF-C, and inhibiting ERK and AKT signaling pathways. Expand
Chemically Induced Hypoxia Enhances miRNA Functions in Breast Cancer
TLDR
Hypoxia enhances miRNA functions following the COX-2/EP4/PI3K/Akt pathways and this pathway can serve as a therapeutic target to abrogate hypoxia and miRNA induced functions in breast cancer. Expand
miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A
TLDR
Downregulation of miR-503-5p at least partially contributes to the tumorigenesis of colon cancer through modulating the angiogenesis and lymphangiogenesis by targeting VEGF-A while stimulating AKT signaling pathways. Expand
Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models
TLDR
The aim of the present review is to highlight the contribution of VEGFs/VEGFR-1 signaling in the progression of different tumor types and to provide an overview of the therapeutic approaches targeting VEGfr-1 currently under investigation. Expand
EP4 as a Therapeutic Target to Impede Breast Cancer-associated Angiogenesis and Lymphangiogenesis
TLDR
It is shown that COX-2 is a major promoter of both events, primarily resulting from the activation of Prostaglandin E receptor EP4 on tumor cells, tumor-infiltrating immune cells, and endothelial cells; and induction of oncogenic microRNAs. Expand
MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets
  • B. Hussen, Sara Tharwat Abdullah, +4 authors M. Taheri
  • Medicine
  • Frontiers in Molecular Biosciences
  • 2021
TLDR
The recent updates on miRNA signatures and their cellular targets in the development of breast tumor angiogenetic are summarized and the strategies associated with miRNA-based therapeutic targets as anti-angiogenic response are discussed. Expand
Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies
TLDR
The current state-of-the-art in BC angiogenesis-mediated by angioregulatory miRNAs is described, and an overview of mi RNAs dysregulation association with the anti-angiogenic response in addition to potential clinical application of miRN as-based therapeutics are described. Expand
miR526b and miR655 Induce Oxidative Stress in Breast Cancer
TLDR
The dynamic functions of miR526b/miR655 in oxidative stress induction in breast cancer are established, and treatment with miRNA-conditioned media upregulates TXNRD1 in both MCF7 and HUVECs, indicating that oxidative stress also induces miRNA overexpression. Expand
Angioregulatory microRNAs in Colorectal Cancer
TLDR
The aim of this article is to review the current literature on angioregulatory miRNAs in CRC and to understand the interaction between these miRNA and their target mRNAs to unravel molecular mechanisms involved in CRC progression. Expand
Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression
TLDR
Using phytochemicals to target miRNAs should have the potential to inhibit tumor growth, progression, invasion and metastasis and may be developed into an effective therapeutic strategy for the treatment of many different cancers where tumor angiogenesis plays a significant role in tumor growth and progression. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 46 REFERENCES
Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer
TLDR
Delivery of miR-494 into human vascular endothelial cells (ECs) enhanced the EC migration and promoted angiogenesis and tumor growth under hypoxic condition and demonstrated that miR -494 is a novel tumor-derived paracrine signal to promote angiogenic and tumor Growth under hypoxia. Expand
Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
TLDR
The role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer is demonstrated and it is indicated that mi R-155 has a pivotal role in tumour angiogenic by downregulation of VHL. Expand
microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
TLDR
In vivo restoration of miR-128 significantly suppressed tumourigenicity of A549 cells in nude mice and inhibited both angiogenesis and lymphangiogenesis of tumour xenografts, and could simultaneously block ERK, AKT and p38 signalling pathways. Expand
Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer
TLDR
A significant association was found between miR-126 expression and tumour progression, nodal metastasis, vessel density, or poor prognosis in OSCC cases. Expand
Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model
TLDR
It is suggested that EP4 antagonists deserve clinical testing for chemo-intervention of lymphatic metastasis in human breast cancer. Expand
COX-2 induces oncogenic micro RNA miR655 in human breast cancer
TLDR
It is shown that Cyclooxygenase-2 over-expression induces an oncogenic microRNA miR655 in human breast cancer cells by activation of EP4 and this expression could serve as a prognostic breast cancer biomarker. Expand
Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer
TLDR
It is shown that cyclooxygenase (COX)-2 expression by breast cancer cells or tumor stroma leading to high PGE2 levels in the tumor milieu promotes lymphangiogenesis and lymphatic metastases, and a case is made for EP4 as a potential therapeutic target for breast cancer. Expand
COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation
TLDR
Novel findings are presented that miRNA 526b is a COX-2 upregulated, oncogenic miRNA promoting SLCs, the expression of which follows EP4 receptor-mediated signaling, and is a promising biomarker for monitoring and personalizing breast cancer therapy. Expand
Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro
TLDR
VEGF-A production by and VEGFR-2 activation on the surface of breast cancer cells indicates the presence of a distinct autocrine signalling loop that enables breast cancers cells to promote their own growth and survival by phosphorylation and activation of VEG FR-2. Expand
MiR-182 promotes proliferation and invasion and elevates the HIF-1α-VEGF-A axis in breast cancer cells by targeting FBXW7.
TLDR
This study showed that overexpression miR-182 regulated actin distribution and filopodia formation to increase invasiveness of breast cancer cells and identified the E3 ubiquitin-protein ligase FBXW7 as a target gene of mi R-182. Expand
...
1
2
3
4
5
...